|
Sorted by: Date | Top Results
|
|
Author |
|
Date |
| |
| |
| 1. |
AMAG Answers 
http://finance.yahoo.com/news/AMAG-Pharmaceuticals
-Provides-bw-3455949158.html?x=0&.v=1
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AMAG Pharmaceuticals, Inc.
|
|
play_tow |
|
5-Feb-10 04:21 pm |
| |
| 2. |
Baird Re-Iterates $53 Target
Action Reiterate Outperform rating, $53 price target.
Earlier this week, we highlighted commentary from
AMAG management indicating Feraheme commercial safety
data is...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AMAG Pharmaceuticals, Inc.
|
|
play_tow |
|
5-Feb-10 10:30 am |
| |
| 3. |
Re: added 2000 $39.16
that can work....but it does require a quick trigger
when shares are up, as today showed. To think AMAG
was trading hands above $52 two weeks ago. It...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AMAG Pharmaceuticals, Inc.
|
|
play_tow |
|
4-Feb-10 03:44 pm |
| |
| 4. |
Re: Near Term Catalysts
This is not so much near-term (next few months), but
as recognition returns to investors that OGXI has
3 Phase III trials launching, the price of...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
30-Jan-10 11:27 am |
| |
| 5. |
Re: $14.87 printed today
OK. Afraid that few investors "survived"
the last 3 months, let alone 3 yrs. Hope the trial
results on OGC-011 are better! And if they are, look
out above....
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
27-Jan-10 01:57 pm |
| |
| 6. |
Re: $14.87 printed today
likely correct. But, if indeed OGXI see's >20
again, say in 2H 2010, then a buy @ $14 sets up for
a 50% gain....not bad. The fact is though that there
is no hurry--- as you say to add shares here, since
a...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
27-Jan-10 01:42 pm |
| |
| 7. |
Re: $14.87 printed today
it may breach $10 afterall
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
27-Jan-10 01:09 pm |
| |
| 8. |
Re: Holding Long
OGX-011 is not the only drug in late phases, showing
efficacy. OGX-427 may be even more lucrative, and
OGXI owns all rights to that, at the moment. http
://www.oncogenex.ca...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
27-Jan-10 12:12 pm |
| |
| 9. |
Re: Holding Long
more like go long BELOW $15.....which is where we are
headed again, Im afraid.
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
27-Jan-10 10:17 am |
| |
| 10. |
Oppenheimer Upgrade to $9
this was 30 October 2009, but the point of posting
again is to read the thesis of Oppenheimer. Not that
the new script data from FRX confirms Oppenheimer's
view that sales of...
Business & Finance > Investments > Stocks (A to Z) > Stocks C >
Cypress Bioscience, Inc.
|
|
play_tow |
|
27-Jan-10 10:16 am |
| |
| 11. |
Re: Is The (a) Bottom In?
Their Q4 and 2009 earnings, in February. That will
give management an opportunity to remind those that
have forgotten the exciting pipeline, their course
to Phase 3 on two compounds, the monetary...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
26-Jan-10 01:32 pm |
| |
| 12. |
Re: Is The (a) Bottom In?
It looks like some traders now believe the technically
driven selling is done, and the trade to the upside
has better prospects. Of...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
26-Jan-10 12:19 pm |
| |
| 13. |
Barclay&&39;s Positive Assessment
from Investor Village board, regarding Barclay's
Top 4 Biotech ideas for 2010....ISIS is one, in part
due to the OGX-011 relation: ___________ barclays
assesment ISIS Pharmaceuticals Key...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
26-Jan-10 10:15 am |
| |
| 14. |
Re: Is The (a) Bottom In?
The fact that we are holding today, in another bloodbath
market day, leads me to agree with you about the $15.58
bottom reached yesterday. I sense that those want
ing...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
22-Jan-10 03:23 pm |
| |
| 15. |
Is The (a) Bottom In?
Shares had a chance to fall hard with the market's
morning decline, but such above yesterday's low,
and now have returned to unchanged. Volume is solid...over
60M shares in...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
22-Jan-10 11:12 am |
| |
| 16. |
Re: Selling Wave Passed?
thanks for that list. Its likely in the February earnings
call that OGXI management will indicate if they are
to present at ASCO. The abstract deadline date has
now passed, so they know today if theyll be...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
22-Jan-10 09:08 am |
| |
| 17. |
Re: Selling Wave Passed?
they have already reported Phase II results on non-small
cell trials. Im not sure what their current trials
are, and what new results might be available. Not
...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
21-Jan-10 03:31 pm |
| |
| 18. |
Re: Selling Wave Passed?
ASCO 2010 ANNUAL Mtg (in Chicago) occurs in early June,
with Abstracts released on line by 20 May. http://www.asco.org/ASCOv2/Meetings/ASCO+Annual+Meeting
Is OGXI...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
21-Jan-10 03:09 pm |
| |
| 19. |
Re: Selling Wave Passed?
I think that is the apt description of the situation.
The stock is currently judged by traders to be unattractive
(witness the price decline in 3 weeks) The company
was recently...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
21-Jan-10 01:52 pm |
| |
| 20. |
TEVA a Suitable Suitor....SeekingAlpha Pt2
High risk product These quibbles are certainly reasonable.
However, at the end of the day, despite the stunning
phase II results announced earlier this year...
Business & Finance > Investments > Stocks (A to Z) > Stocks O >
OncoGenex Pharmaceuticals, Inc.
|
|
play_tow |
|
21-Jan-10 12:48 pm |
| |
